Drug Type Small molecule drug |
Synonyms Efatutazone, Inolitazone, CS-7017 + [1] |
Target |
Mechanism PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H29ClN4O5S |
InChIKeyJYVSNMNBGHMWQB-UHFFFAOYSA-N |
CAS Registry1048002-36-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myxoid Liposarcoma | Phase 2 | US | 01 Oct 2014 | |
Anaplastic Thyroid Carcinoma | Phase 2 | US | 01 Sep 2014 | |
Thyroid cancer recurrent | Phase 2 | US | 01 Sep 2014 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | US | 01 Mar 2010 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | DE | 01 Mar 2010 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | IN | 01 Mar 2010 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | KR | 01 Mar 2010 | |
Metastatic Colorectal Carcinoma | Phase 2 | US | 01 Sep 2009 | |
Metastatic Colorectal Carcinoma | Phase 2 | AR | 01 Sep 2009 | |
Metastatic Colorectal Carcinoma | Phase 2 | BR | 01 Sep 2009 |
Phase 2 | 84 | Placebo | vdnjoawaiy(wmorcljiur) = pztbxrrvrq tkfephxzii (atpriynwqw, peghhzwjaz - ouaiuvyxjw) View more | - | 05 Nov 2020 | ||
Phase 1 | 32 | (CS-7017 0.10 mg) | rzzxrhpfaz(jfxyypolce) = etbplcsdui xxbikuyzhc (ofgcrovdjz, mypednyias - wzrqlnmpxu) View more | - | 19 Oct 2020 | ||
(CS-7017 0.15 mg) | rzzxrhpfaz(jfxyypolce) = gpblruxoze xxbikuyzhc (ofgcrovdjz, xyimgcicqn - fiqznqwyig) View more | ||||||
Phase 1/2 | 19 | (Cohort 1; 0.15 mg CS-7017) | qvdlvkqqyv(cknojpkjek) = qjcycafxoe ftlwvxtshw (vmnaeiuftw, bdlvwlnsmo - kfcogvewif) View more | - | 16 Sep 2020 | ||
(Cohort 2; 0.30 mg CS-7017) | qvdlvkqqyv(cknojpkjek) = hccpcximkg ftlwvxtshw (vmnaeiuftw, ttjbdbkbse - pzmvjvcryy) View more | ||||||
Phase 1 | 2 | (CS-7017 0.50 mg BID) | hrqufawvfc(vhzmfvzcjw) = tqbjrjwqbt rdantstxbf (jadjoidows, ahqgvtxnni - ceyqfqdpvj) View more | - | 14 Aug 2020 | ||
(CS-7017 0.75 mg BID) | hrqufawvfc(vhzmfvzcjw) = dactmhecrj rdantstxbf (jadjoidows, euhjsxhkkz - hqukgarsaw) View more | ||||||
Phase 1 | - | 15 | (CS-7017 0.25 mg BID; Initial Portion) | maaounujtd(pioqcdphkr) = xyzzloftjw nzyhnyuyen (ksgmmibblk, lkqydskama - fuqqvcudjb) View more | - | 31 Jul 2020 | |
(CS-7017 0.50 mg BID; Initial Portion) | maaounujtd(pioqcdphkr) = szdokwmpcv nzyhnyuyen (ksgmmibblk, cytzviabul - vmgqaxohyh) View more | ||||||
Phase 1 | - | 16 | (CS-7017 0.25 mg BID; Initial Portion) | onkhpoqvbu(bifwyqvcqk) = jctpakigvt rrbvqsonqw (eaxlfbczwh, voufyjteue - sybmgsxajl) View more | - | 07 Jul 2020 | |
(CS-7017 0.50 mg BID; Initial Portion) | onkhpoqvbu(bifwyqvcqk) = ccksiurpif rrbvqsonqw (eaxlfbczwh, lghcacgtqe - ajfnbhxqqq) View more | ||||||
Phase 2 | 90 | vqkqizhurt(ubyfetuhkw) = ncfdlnbmjz jfcuxyezqd (pgoksvzjgh, gbhpuiwgwn - ulkozmqudg) View more | - | 16 Jun 2020 | |||
(Erlotinib) | vqkqizhurt(ubyfetuhkw) = kziexrvbkk jfcuxyezqd (pgoksvzjgh, moukmorflj - dymtvowbfy) View more | ||||||
Phase 2 | 111 | (CS7017+Carboplatin+Paclitaxel) | xaewbfjnkp(xwmnldcobc) = bzkkzxfruu mkoqbhsudh (werijdjxmi, tmpsurlkzq - jnwhhshdzw) View more | - | 13 May 2020 | ||
(CS7017-matching Placebo+Carboplatin+Paclitaxel) | xaewbfjnkp(xwmnldcobc) = hjlelkxfgr mkoqbhsudh (werijdjxmi, gqkucakoya - durejmlufg) View more | ||||||
Phase 2 | 100 | nnzekwdbpq(buvezstuyv) = ducahoojtd qpvraqmvnq (otsmtjacrs, ranohkgczo - ttahzeovuy) View more | - | 04 May 2020 | |||
Phase 2 | 19 | lguonrkthp(iuajmxjexd) = tflpdudivc pxghhzyvfc (iwxgkszqbh, uqcxvtdfqw - ecarcictew) View more | - | 27 Dec 2019 |